辉瑞再回第一?礼来跻身前十,GSK无奈落榜,全球制药营收TOP10格局生变

E药经理人
26 Nov 2024

跨国药企三季报发布后,全球制药营收TOP10又迎新格局。辉瑞成功突破业绩下滑困局,不仅一举登上榜首,更是Q3业绩增速最快的MNC;礼来成功超越GSK进榜TOP10;强生、BMS正在艰难守位中……撰文| Erin不出意外,2025年全球制药营收TOP10格局又将巨变。图丨2024年前三季度全球制药营收TOP10首先是辉瑞,如果说今年上半年因为辉瑞两次公布成本削减计划和接连裁员,业界还在为其跌落神坛...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10